Back

Feasibility and safety of a 100% transfemoral approach for TAVI - a 4-year experience    

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Vascular complications in TAVI Aortic Valve Intervention ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Francesco Filice

Alma Mater Studiorum, University of Bologna, Bologna (Italy)

5 More presentations in this session

Presentation thumbnail
Vascular complications following TAVI: safety and predictors of the MANTA vascular closure device
Doctor T. Carlos (Coimbra, PT)
Abstract Slides Video
Presentation thumbnail
Low femoral artery puncture for transfemoral TAVR
Doctor V. Jeyalan (Middlesbrough, GB)
Abstract Slides Video
Presentation thumbnail
Sex difference in characteristics and outcomes for transcatheter aortic valve implantation: a nationwide japanese study
Doctor K. Mitsui (Suita, JP)
Abstract Slides Video
Presentation thumbnail
Incidence and predictors of complications after transcatheter aortic valve implantation (TAVI) according to VARC-3 criteria: a systematic review and meta-analysis
Doctor F. Giacobbe (Turin, IT)
Abstract Slides Video
Presentation thumbnail
Does obesity impact outcomes in TAVI? A systematic review and meta-analysis
Mr L. Dexheimer Da Silva (Sao Paulo, BR)
Abstract Slides Video

Access the full session

Session thumbnail
Vascular complications in TAVI

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Single arterial access versus standard access in TAVI: results from a large multicenter registry
thumbnail
Congress Presentation
Long-term clinical and imaging outcomes of patients undergoing percutaneous femoral intervention following TAVI-related vascular access complications
thumbnail
Congress Presentation
Optimizing transcatheter aortic valve replacement safety: the role of secondary access in minimizing vascular complications

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources